Publication | Open Access
Integrin α<sub>v</sub>β<sub>3</sub> Imaging of Radioactive Iodine–Refractory Thyroid Cancer Using <sup>99m</sup>Tc-3PRGD2
68
Citations
21
References
2012
Year
The RAIR ((131)I WBS-negative/thyroglobulin-positive) metastatic lesions can be traced using (99m)Tc-3PRGD2 imaging, meaning these lesions are highly neovascularized. (99m)Tc-3PRGD2 angiogenesis imaging can be used for the localization and growth evaluation of RAIR lesions, providing a new therapeutic target and a novel imaging modality to monitor the efficacy of certain antiangiogenetic therapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1